-
Doctors Urge Need for ‘Common Sense Oncology’A movement of health care professionals say the toll of many cancer treatments is out of sync with the purported benefits.
by Kyle Bagenstose
-
2023: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting and essays of 2023.
by Cancer Today staff
-
Emerging Treatments for Brain Metastases in Breast CancerSABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
by Marci A. Landsmann
-
Cancer Today Editors’ Picks: 2023The editors of Cancer Today share the stories that most resonated with readers in 2023.
-
Patient Advocates as Research PartnersSpeakers at SABCS discuss how people who have lived with breast cancer can be valuable partners in research.
by Eric Fitzsimmons
-
Understanding Side Effects and the Patient ExperienceResearchers focus on assessing quality of life and toxicity risks in people with breast cancer.
by Thomas Celona
-
Addressing Social Determinants of HealthSpeakers at SABCS discuss measuring and meeting social factors that affect the health and outcomes of breast cancer patients.
by Kevin McLaughlin
-
Exercise Benefits in Metastatic Breast CancerStudy finds supervised physical activity can help improve quality of life and reduce fatigue among people with metastatic breast cancer.
by Thomas Celona
-
Finding Answers in Prostate CancerPSMA PET imaging is helping clinicians more accurately stage prostate cancer and provide precision treatment.
by Sandra Gordon
-
Is Chemo-free Treatment Coming for HER2-positive Breast Cancer?Evidence grows that some people with HER2-positive breast cancer may do well on HER2-targeted therapy alone.
by Myles Starr
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
